Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season
Sanofi announced today the immediate adoption of influenza strains selected by the US Food and Drug Administration ...
Sanofi: Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant ...